Jarislowsky, Fraser LTD Viatris Inc Transaction History

Jarislowsky, Fraser LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Sep 27, 2024	BUY	$8.72 - $11.56 $138,709 - $183,884	15,907 New	15,907 $177,000
Q4 2022 Feb 10, 2023	SELL	$8.72 - $11.56 $7,664 - $10,161	-879 Reduced 5.24%	15,907 $177,000
Q3 2022 Nov 07, 2022	SELL	$8.48 - $11.13 $10,472 - $13,745	-1,235 Reduced 6.85%	16,786 $143,000
Q2 2022 Jul 27, 2022	SELL	$9.95 - $12.27 $90,515 - $111,620	-9,097 Reduced 33.55%	18,021 $188,000
Q1 2022 May 12, 2022	SELL	$9.81 - $15.4 $39,740 - $62,385	-4,051 Reduced 13.0%	27,118 $295,000
Q4 2021 Feb 10, 2022	SELL	$12.09 - $14.68 $261,011 - $316,926	-21,589 Reduced 40.92%	31,169 $421,000
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $72,994 - $83,351	-5,509 Reduced 9.45%	52,758 $714,000
Q2 2021 Aug 09, 2021	SELL	$12.97 - $16.15 $112,255 - $139,778	-8,655 Reduced 12.93%	58,267 $832,000
Q1 2021 May 13, 2021	SELL	$13.59 - $18.54 $98,242 - $134,025	-7,229 Reduced 9.75%	66,922 $934,000
Q4 2020 Feb 11, 2021	BUY	$14.3 - $18.74 $1.06 Million - $1.39 Million	74,151 New	74,151 $1.39 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

Stay updated on Jarislowsky, Fraser LTD with notifications on news.